Jupiter Endovascular appointed interventional cardiologist Catalin Toma, MD, as Chief Medical Officer,a newly created global role. Dr. Toma was a Global Coprincipal Investigator of SPIRARE II pivotal ...

The FDA granted 510(k) clearance to Vesalio’s pVasc Net peripheral mechanical thrombectomy device. The device incorporates a fine-pore, dual-layer distal filter intended to capture clot fragments ...

The Advanced Research Projects Agency for Health (ARPA-H), an agency within the United States Department of Health and Human Ser ...

Penumbra announced today that Donald Frei, MD, will serve as Associate Chief Medical Officer of Neuro. The press release stat ...

Vexev, an Australia-based medical robotics company, announced it has raised $6 million in new funding to accelerate the path to ...

Fluidx Medical Technology, Inc., a developer of embolic technologies, announced the closing of financing that will fund the devel ...

Salus Scientific Corporation announced the closing of its oversubscribed Series A financing, raising a total of $10.1 million.

The Society for Cardiovascular Angiography & Interventions (SCAI) and the Society of Interventional Radiology announced that ...

Xeltis, a Netherlands-based developer of implants that enable the natural creation of living and long-lasting vessels, ...

Galaxy Therapeutics, a company focused on the treatment of intracranial aneurysms, announced it has received CE Mark approval for ...